.
Most patients with resistance to thyroid hormone (RTH) test negative in newborn screening
(NBS) for congenital hypothyroidism (CH). Here, we present a case of RTH diagnosed through
NBS. The patient presented to us after her NBS for CH revealed high TSH (23.4 µIU/mL) and
free T4 (FT4) (5.40 ng/dL) levels. Apart from tachycardia, she exhibited no other
manifestations related to excess or deficiency of thyroid hormones. A confirmatory test
replicated the findings, showing elevated serum TSH levels (35.7 µIU/mL) along with high
FT4 levels (5.84 ng/dL). Ultrasonography showed marked thyroid gland enlargement (> +4
SD). Targeted next-generation sequencing of genes associated with genetic thyroid
disorders revealed a previously reported
THRB
variant, p.Gly345Cys.
Unexpectedly, two biallelic
DUOX2
variants (p.His678Arg and p.Arg1334Trp)
were also detected. At her last visit, no significant issues were observed with
neurological development, growth, bone maturation, or gastrointestinal symptoms related to
thyroid function at the age of 1 year, without treatment for RTH and CH. During follow-up,
the TSH and FT4 levels gradually decreased. In conclusion, we report a patient with
simultaneous RTH and
DUOX2
defects, demonstrating the value of conducting
a comprehensive analysis of multiple genes associated with thyroid diseases to better
comprehend the pathogenesis in patients with atypical thyroid-related phenotypes.